Atlas Trials

Evaluation of Topical Rebamipide Versus Topical Betamethasone for Management of Oral Ulcers in Behcet's Disease

Clinical trial NCT06084624 · UNKNOWN

Trial details

NCT number
NCT06084624
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Oral Ulceration Due to Behçet's Disease
Start date
2023-12-01
Primary completion
2025-01-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.